NeuroFine dba InNeuroco has filed a notice of an exempt offering of securities to raise $3,951,908.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, NeuroFine dba InNeuroco is raising $3,951,908.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Marc Litzenberg played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About NeuroFine dba InNeuroco
InNeuroCo’s mission is to create and deliver high-quality complex catheter solutions. Dedicating time and resources to design and develop safe revolutionary technology, which industry leaders and doctors not only approve of but also depend on. InNeuroCo brings together brilliant minds in science and engineering with access to the most advanced neurovascular technologies to build life-saving medical devices that go the distance. When it comes to your life, we don’t outsource our materials outside of the U.S. We insource high caliber U.S.-made materials to ensure high quality and safety because your life depends on it.
To learn more about NeuroFine dba InNeuroco, visit http://www.inneuroco.com/
Contact:
Marc Litzenberg, Chief Executive Officer
954-742-5988
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.